Temporal and within practice variability in the health improvement network

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 9, 2011, Pages 948-955

  Haynes, Kevin ^a   Bilker, Warren B ^a   Tenhave, Tom R ^a   Strom, Brian L ^a,b   Lewis, James D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Databases; Epidemiology; Incidence

Indexed keywords

ARTICLE; CANCER INCIDENCE; CLINICAL PRACTICE; CONTROLLED STUDY; HEALTH; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; OBESITY; PHARMACOEPIDEMIOLOGY; POISSON DISTRIBUTION; PRIORITY JOURNAL; SMOKING;

DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; FAMILY PRACTICE; GREAT BRITAIN; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MODELS, THEORETICAL; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; TIME FACTORS;

EID: 80052374152     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2191     Document Type: Article

References (29)

1. Tannen RL, Weiner MG, Xie D. Replicated studies of two randomized trials of angiotensin-converting enzyme inhibitors: further empiric validation of the 'prior event rate ratio' to adjust for unmeasured confounding by indication. Pharmacoepidemiol Drug Saf 2008; 17(7): 671-685.
2. Weiner MG, Xie D, Tannen RL. Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding. Pharmacoepidemiol Drug Saf 2008; 17(7): 661-670.
3. Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, Petersen I. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf 2010; 19(6): 618-626.
4. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004; 12(3): 171-177.
5. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009; 18(2): 120-131.
6. Lo Re V, III, Haynes K, Forde KA, Localio AR, Schinnar R, Lewis JD. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf 2009; 18(9): 807-814.
7. Ruigomez A, Martin-Merino E, Rodriguez LA. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 2010; 19(6): 579-585.
8. Margulis AV, Garcia Rodriguez LA, Hernandez-Diaz S. Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf 2009; 18(10): 900-909.
9. Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in The Health Improvement Network. Pharmacoepidemiol Drug Saf 2009; 18(8): 730-736.
10. Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009; 18(1): 76-83.
11. Bhayat F, Das-Gupta E, Smith C, McKeever T, Hubbard R. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer 2009; 9: 252.
12. Lewis JD, Brensinger C. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf 2004; 13(7): 437-441.
13. Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009; 18(4): 269-275.
14. Bhayat F, Das-Gupta E, Smith C, Hubbard R. NSAID use and risk of leukaemia: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009; 18(9): 833-836.
15. Rait G, Walters K, Griffin M, Buszewicz M, Petersen I, Nazareth I. Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry 2009; 195(6): 520-524.
16. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005; 14(7): 443-451.
17. Hippisley-Cox J, Vinogradova Y. Trends in Consultation Rates in General Practice 1995 to 2008: Analysis of the QResearch® database. The Health and Social Care Information Centre, 2009.
18. Gardiner JC, Luo Z, Roman LA. Fixed effects, random effects and GEE: what are the differences? Stat Med 2009; 28(2): 221-239.
19. Gibbons RD, Hur K, Bhaumik DK, Bell CC. Profiling of county-level foster care placements using random-effects Poisson regression models. Health Serv Outcomes Res Method 2007; 7: 97-108.
20. Omar RZ, O'Sullivan C, Petersen I, Islam A, Majeed A. A model based on age, sex, and morbidity to explain variation in UK general practice prescribing: cohort study. BMJ 2008; 337: a238.
21. Sullivan CO, Omar RZ, Ambler G, Majeed A. Case-mix and variation in specialist referrals in general practice. Br J Gen Pract 2005; 55(516): 529-533.
22. Sullivan CO, Omar RZ, Forrest CB, Majeed A. Adjusting for case mix and social class in examining variation in home visits between practices. Fam Pract 2004; 21(4): 355-363.
23. de Lusignan S, Chan T, Wood O, Hague N, Valentin T, Van Vlymen J. Quality and variability of osteoporosis data in general practice computer records: implications for disease registers. Public Health 2005; 119(9): 771-780.
24. Dunnell K. Ageing and mortality in the UK--national statistician's annual article on the population. Popul Trends 2008; (134): 6-23.
25. The NHS Information Centre PSU. Prescriptions Dispensed in the Community Statistics for 1998 to 2008: England. The Health and Social Care Information Centre, 2009.
26. Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care 2003; 12(1): 29-34.
27. Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'. J Public Health (Oxf) 2007; 29(1): 40-47.
28. Britten N, Ukoumunne O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ 1997; 315(7121): 1506-1510.
29. Gallagher AM, Thomas JM, Hamilton WT, White PD. Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001. J R Soc Med 2004; 97(12): 571-575.